X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3173) 3173
Publication (370) 370
Book Review (30) 30
Book Chapter (21) 21
Conference Proceeding (6) 6
Dissertation (4) 4
Book / eBook (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2065) 2065
animals (2021) 2021
humans (1267) 1267
parasitology (1109) 1109
leishmaniasis (1006) 1006
leishmania (970) 970
parasitic diseases (924) 924
visceral leishmaniasis (923) 923
mice (790) 790
parasites (672) 672
female (645) 645
antiprotozoal agents - pharmacology (637) 637
microbiology (604) 604
immunology (532) 532
cutaneous leishmaniasis (507) 507
mice, inbred balb c (487) 487
infectious diseases (479) 479
leishmania infantum - drug effects (449) 449
male (449) 449
research article (445) 445
biochemistry & molecular biology (435) 435
leishmania infantum (429) 429
analysis (417) 417
research (415) 415
tropical medicine (408) 408
health aspects (385) 385
leishmaniasis, visceral - parasitology (373) 373
leishmaniasis, visceral - drug therapy (364) 364
leishmania - drug effects (359) 359
promastigotes (352) 352
proteins (345) 345
pharmacology & pharmacy (343) 343
in-vitro (340) 340
macrophages (328) 328
dogs (312) 312
antiprotozoal agents - therapeutic use (310) 310
kala-azar (307) 307
donovani (305) 305
drug resistance (294) 294
infection (287) 287
medicine (275) 275
macrophages - parasitology (259) 259
chemistry, medicinal (257) 257
infections (257) 257
leishmaniasis, visceral - immunology (244) 244
tropical diseases (241) 241
leishmania donovani - drug effects (232) 232
chemotherapy (230) 230
infantum (228) 228
protozoan proteins - genetics (228) 228
vector-borne diseases (227) 227
antiprotozoal agents - chemistry (226) 226
amastigotes (225) 225
biology (223) 223
drugs (221) 221
arctic medicine. tropical medicine (217) 217
care and treatment (214) 214
cell line (214) 214
diagnosis (214) 214
protozoan proteins - metabolism (214) 214
gene expression (207) 207
physiological aspects (207) 207
genetic aspects (206) 206
leishmania donovani (202) 202
leishmaniasis - drug therapy (202) 202
expression (196) 196
trypanosoma-cruzi (194) 194
public aspects of medicine (193) 193
apoptosis (192) 192
enzymes (191) 191
inhibitory concentration 50 (184) 184
leishmaniasis, cutaneous - parasitology (183) 183
antileishmanial activity (181) 181
miltefosine (180) 180
biology and life sciences (179) 179
cell biology (179) 179
leishmania - genetics (179) 179
molecular sequence data (179) 179
vaccines (179) 179
disease models, animal (176) 176
leishmaniasis - parasitology (176) 176
leishmaniasis, visceral - veterinary (175) 175
parasitic sensitivity tests (173) 173
life sciences (172) 172
amino acid sequence (169) 169
dna (167) 167
adult (166) 166
immune response (162) 162
drug-resistance (158) 158
macrophages - drug effects (157) 157
multidisciplinary sciences (156) 156
leishmania infantum - genetics (155) 155
leishmania infantum - immunology (155) 155
structure-activity relationship (155) 155
cells (153) 153
identification (150) 150
cells, cultured (149) 149
science (149) 149
resistance (148) 148
medicine and health sciences (147) 147
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3177) 3177
Spanish (6) 6
Russian (4) 4
French (3) 3
German (3) 3
Dutch (1) 1
Persian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Parasitology International, ISSN 1383-5769, 2016, Volume 66, Issue 2, pp. 47 - 55
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
Visceral leishmaniasis is a fatal parasitic neglected disease affecting 1.5 million people worldwide. Based on a drug repositioning approach, the aim of this... 
Therapy | Drug delivery | Liposomes | Leishmania | PARASITES | PHAGOCYTOSIS | liposomes | DONOVANI | therapy | BONE-MARROW | HOST | MICROBIOLOGY | drug delivery | RELEASE | MICE LACKING | INJECTION | PHARMACOLOGY & PHARMACY | L. CHAGASI | Bone Marrow - immunology | Spleen - immunology | Male | Leishmaniasis, Visceral - immunology | Spleen - drug effects | Administration, Cutaneous | Tumor Necrosis Factor-alpha - agonists | Macrophages - parasitology | Leishmania infantum - growth & development | Liver - immunology | Liver - drug effects | Leishmaniasis, Visceral - parasitology | Interleukin-10 - agonists | Macrophages - immunology | Bone Marrow - drug effects | Disease Models, Animal | Cricetinae | Immunologic Factors - chemistry | Drug Compounding - methods | Parasite Load | Naphthoquinones - pharmacology | Antiprotozoal Agents - chemistry | Interleukin-6 - agonists | Static Electricity | Antiprotozoal Agents - pharmacology | Leishmaniasis, Visceral - drug therapy | Spleen - parasitology | Bone Marrow - parasitology | Liposomes - chemistry | Animals | Nanostructures - administration & dosage | Leishmania infantum - drug effects | Chemokine CCL2 - biosynthesis | Interleukin-6 - biosynthesis | Nanostructures - chemistry | Chemokine CCL2 - agonists | Interleukin-10 - biosynthesis | Macrophages - drug effects | Naphthoquinones - chemistry | Mice | Liver - parasitology | Tumor Necrosis Factor-alpha - biosynthesis | Immunologic Factors - pharmacology | Liposomes - pharmacokinetics
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 02/2012, Volume 67, Issue 2, pp. 387 - 397
Journal Article
PLOS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, p. e0154101
During the last decade miltefosine (MIL) has been used as first-line treatment for visceral leishmaniasis in endemic areas with antimonial resistance, but a... 
TRANSLOCATION | TRANSPORTER | INDIAN VISCERAL LEISHMANIASIS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | PAROMOMYCIN | IN-VITRO SELECTION | KALA-AZAR | DRUG-RESISTANCE | L.-DONOVANI | FAILURE | Parasitic Sensitivity Tests | Genome, Protozoan | Gene Expression Regulation | Selection, Genetic | Genotype | Phosphorylcholine - analogs & derivatives | Protozoan Proteins - genetics | Antiprotozoal Agents - pharmacology | Genetic Complementation Test | Life Cycle Stages - genetics | Carrier Proteins - genetics | Drug Resistance - genetics | Leishmania infantum - growth & development | Phenotype | Carrier Proteins - metabolism | Protozoan Proteins - metabolism | Biological Transport | Phosphorylcholine - pharmacology | Leishmania infantum - drug effects | High-Throughput Nucleotide Sequencing | Leishmania infantum - metabolism | Mutation | Leishmania infantum - genetics | Life Cycle Stages - drug effects | Drug resistance in microorganisms | Kala-azar | Leishmania | Physiological aspects | Genetic aspects | Research | Drug therapy | Promastigotes | Clinical isolates | Genomes | Parasites | Gene deletion | Drug resistance | Inactivation | Gene sequencing | Coupling (molecular) | Transfection | Clonal deletion | Acquired immune deficiency syndrome--AIDS | Parasitic diseases | Visceral leishmaniasis | Human immunodeficiency virus--HIV | Deletion | Deoxyribonucleic acid--DNA | Vector-borne diseases | Genomic analysis | Deactivation | Cloning | Stop codon | Exploration | Leishmaniasis | Amastigotes | Gene expression | Corrosion resistance | Miltefosine | Aberration | Intracellular | Laboratory animals | Transporter | Life Sciences | Microbiology and Parasitology | Parasitology | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e81899
Journal Article